USMLE Reproductive: Ovarian Pathology—Cysts, PCOS, Tumors, Markers

Ovarian Pathology: Cysts, PCOS, Tumors — Markers

What This Is and Why It Matters for USMLE

Ovarian pathology is a high-yield topic for Step 1 and Step 2 CK, with a moderate frequency on Step 3. It covers the pathophysiology, clinical presentation, diagnostic approach, and management of ovarian cysts, polycystic ovary syndrome (PCOS), and ovarian tumors. Understanding the key facts and clinical correlations is essential for diagnosing and managing patients with these conditions.

High-Yield Facts (What You Must Memorize)

• Pathophysiology:
  • Ovarian cysts: functional or neoplastic
  • PCOS: insulin resistance, hyperandrogenism, and ovarian stroma hyperplasia
  • Ovarian tumors: benign or malignant, epithelial or germ cell
• Classic presentation and physical exam findings:
  • Ovarian cysts: pelvic pain, palpable mass
  • PCOS: hirsutism, acne, oligomenorrhea
  • Ovarian tumors: abdominal pain, palpable mass, weight loss
• Diagnostic approach:
  • Labs: CA-125, AFP, beta-hCG
  • Imaging: ultrasound, CT, MRI
• First-line treatment and management:
  • Ovarian cysts: watchful waiting, surgery
  • PCOS: metformin, birth control pills
  • Ovarian tumors: surgery, chemotherapy
• Red flags, complications, and follow-up:
  • Ovarian cancer: abdominal pain, weight loss, palpable mass
  • PCOS: infertility, gestational diabetes
  • Ovarian cysts: torsion, rupture

Clinical Pearls & Buzzwords

• CA-125: ovarian cancer marker
• PCOS: insulin resistance, hyperandrogenism, and ovarian stroma hyperplasia
• Ovarian torsion: surgical emergency
• Malignant transformation: risk of ovarian cancer

Step-by-Step Clinical Reasoning

1. Identify the syndrome or presentation.
2. Generate a differential (most likely and must-not-miss):
   • Ovarian cysts: functional or neoplastic
   • PCOS: insulin resistance, hyperandrogenism, and ovarian stroma hyperplasia
   • Ovarian tumors: benign or malignant, epithelial or germ cell
3. Order appropriate initial tests:
   • Labs: CA-125, AFP, beta-hCG
   • Imaging: ultrasound, CT, MRI
4. Interpret results:
   • CA-125: elevated in ovarian cancer
   • AFP: elevated in germ cell tumors
   • beta-hCG: elevated in choriocarcinoma
5. Initiate treatment and monitoring:
   • Ovarian cysts: watchful waiting, surgery
   • PCOS: metformin, birth control pills
   • Ovarian tumors: surgery, chemotherapy

Missing a life-threatening complication: ovarian torsion or rupture.

Common Mistakes & Exam Traps

• The mistake: Failing to consider ovarian cancer in a patient with a palpable mass.
• Why it happens: Misunderstanding the risk factors and clinical presentation.
• How to avoid it: Consider ovarian cancer in any patient with a palpable mass, especially if accompanied by abdominal pain or weight loss.

• Exam board insight: The examiners will penalize you for missing a life-threatening complication.

• The mistake: Failing to diagnose PCOS in a patient with hirsutism and oligomenorrhea.

• Why it happens: Misunderstanding the diagnostic criteria and clinical presentation.
• How to avoid it: Consider PCOS in any patient with hirsutism and oligomenorrhea, especially if accompanied by insulin resistance.
• Exam board insight: The examiners will penalize you for missing a common endocrine disorder.

How It’s Tested on USMLE

• Step 1: Basic science vignette (e.g., molecular mechanism, pathology slide, pharmacology).
• Step 2 CK: Clinical vignette (e.g., "A 45-year-old with chest pain..."). Focus on next step in diagnosis or treatment.
• Step 3: Similar to Step 2 CK, plus prognosis, risk factors, and occasionally CCS management.

Note common distractors and NBME tricks:

• Distractor: Failing to consider ovarian cancer in a patient with a palpable mass.
• NBME trick: Using a clinical vignette with a patient presenting with abdominal pain and a palpable mass, and asking you to consider ovarian cancer as a diagnosis.

CCS (Step 3) Relevance (If Applicable)

If this topic appears in Step 3 Computer-based Case Simulations, provide a short strategy:

• Initial orders: Order a pelvic ultrasound and CA-125 to evaluate for ovarian cysts or cancer.
• Monitoring and follow-up: Follow up with the patient in 1-2 weeks to re-evaluate the ultrasound and CA-125 levels.
• Common mistakes: Failing to order indicated tests or delaying treatment.

Practice Questions (3-5 single-best-answer)

Question 1: A 35-year-old woman presents with a palpable mass in the pelvis and abdominal pain. What is the most likely diagnosis?

A) Ovarian cyst B) PCOS C) Ovarian tumor D) Endometriosis

Answer: C) Ovarian tumor

Explanation: The patient's presentation of a palpable mass and abdominal pain is consistent with an ovarian tumor. The examiners will penalize you for missing a life-threatening complication.

Question 2: A 25-year-old woman presents with hirsutism and oligomenorrhea. What is the most likely diagnosis?

A) PCOS B) Cushing's syndrome C) Congenital adrenal hyperplasia D) Androgen insensitivity syndrome

Answer: A) PCOS

Explanation: The patient's presentation of hirsutism and oligomenorrhea is consistent with PCOS. The examiners will penalize you for missing a common endocrine disorder.

Quick Reference Card (60-Second Summary)

• CA-125: ovarian cancer marker
• PCOS: insulin resistance, hyperandrogenism, and ovarian stroma hyperplasia
• Ovarian torsion: surgical emergency
• Malignant transformation: risk of ovarian cancer
• First-line treatment: watchful waiting, surgery, metformin, birth control pills

If You Get Stuck on Test Day

• How to eliminate obviously wrong answers: Use the process of elimination to eliminate answers that are not consistent with the patient's presentation.
• How to use the "next best step" hierarchy: Use the hierarchy to determine the next best step in diagnosis or treatment.
• For Step 3 CCS: Order basic labs and vitals, and consider ordering an ultrasound or CT scan.

Related USMLE Topics

• Endometriosis: connects to ovarian cancer, pelvic pain, and infertility.
• Infertility: connects to PCOS, endometriosis, and ovarian cancer.
• Gynecologic malignancies: connects to ovarian cancer, cervical cancer, and endometrial cancer.